Experiment 449814
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | BURRIS,H: IRVIN,R: KUHN,J: KOLTER,S: SMITH,L: SHAFFER,D: FIELDS,S: WEISS,G: ECKARDT,J: RODRIGUEZ,G: RINOLDI,D: WALL,J: COOK,G: SMITH,S: VREELAND,F: BAYSSAS,M: LE BAIL,N: VON HOFF,D:. (1993). PHASE I CLINICAL TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR 6-HOUR INTRAVENOUS INFUSION.. 11(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | 58 PATIENTS WITH A VARIETY OF SOLID TUMORS REFRACTORY TO CONVENTIONAL THERAPY WERE USED IN THIS PHASE 1 STUDY. PATIENTS WERE GIVEN INFUSIONS EVERY 21 DAYS. THE DOSE LIMITING TOXICITY WAS NEUTROPENIA. OTHER TOXICITIES INCLUDED MUCOSITIS, RASH, ALOPECIA AND HYPERSENSITIVITY REACTIONS. 5 PATIENTS SHOWED PARTIAL RESPONSES AND 10 PATIENTS HAD MINOR RESPONSES. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |